Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Infarct

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Infarct in 2 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dufour, M1
Payet, C1
Gillet, A1
Hurault de Ligny, B1
El Haggan, W1
Comoz, F1
Lobbedez, T1
Pujo, M1
Griveau, AM1
Bottet, P1
Bensadoun, H1
Ryckelynck, JP1

Other Studies

2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Infarct

ArticleYear
[Bilateral renal infarction and ecstasy].
    Journal des maladies vasculaires, 2014, Volume: 39, Issue:4

    Topics: Abdomen, Acute; Adult; Alcohol Drinking; Anticoagulants; Drug Synergism; Heparin, Low-Molecular-Weig

2014
Early loss of two renal grafts obtained from the same donor: role of ecstasy?
    Transplantation, 2005, Jul-15, Volume: 80, Issue:1

    Topics: Adult; Glomerulonephritis, IGA; Hallucinogens; Histocompatibility Testing; Humans; Infarction; Kidne

2005